Onset of Glycemic and Weight Outcomes in Patients Initiating Exenatide Once Weekly: The Relationship of Exenatide Exposure with Efficacy over the First 24 Weeks of Treatment

por Blevins, Thomas, Ruggles, James, Hardy, Elise
Publicado 2016

Exenatide once weekly improved 24‐hour glucose control and reduced glycaemic variability in metformin‐treated participants with type 2 diabetes: a randomized, placebo‐controlled tr...

por Frías, Juan P., Nakhle, Samer, Ruggles, James A., Zhuplatov, Sergey, Klein, Eric, Zhou, Rong, Strange, Poul
Publicado 2016

Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights fr...

por Clegg, Lindsay E., Penland, Robert C., Bachina, Srinivas, Boulton, David W., Thuresson, Marcus, Heerspink, Hiddo J. L., Gustavson, Stephanie, Sjöström, C. David, Ruggles, James A., Hernandez, Adrian F., Buse, John B., Mentz, Robert J., Holman, Rury R.
Publicado 2019